Skip to main content
. 2018 Aug 6;11:4573–4582. doi: 10.2147/OTT.S170722

Figure 3.

Figure 3

Difference between the absolute SLD of target lesions (nintedanib arm – placebo arm) at different time intervals.

Note: The degree of SLD difference shows the degree of response to treatment.

Abbreviations: NSCLC, non-small-cell lung cancer; PD-FLT, progressive disease as the best response to first-line therapy; SLD, sum of longest diameter; TSFLT, time from start of first-line therapy.